Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 27,500 shares at $28.32 ($783K) on 2020-03-03, disclosed to the SEC on 2020-03-05.
Open-market sale of $783k HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.32 | 23,600 | $668K | 85.4% |
| 2 | $29.33 | 3,900 | $114K | 14.6% |
| Total | $28.46 avg | 27,500 | $783K | 100% |
| Filing → |
| HCAT | SELL | 2020-07-06 | $795K | — | Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |